Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/RMD
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

ResMed Inc. (RMD) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.
Read full analysis

Key Stats

  • Market Cap
    $31.89B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $283.28
  • 52W Low
    $182.82
  • Typical Hold Time
    -
  • Enterprise Value
    $31.24B
  • Div Yield
    1.19%
  • Trading Activity
    -
$219.5
52W Low: $182.82
02 Jun 2026
52W High: $283.28
07 Oct 2025

Track ResMed Inc. (RMD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ResMed Inc. has traded between a low of $182.82 and a high of $283.28, highlighting its annual price range. Buy and sell ResMed Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Most Recent News

Content is generated by Aura AI

Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.

Coinbase CEO Brian Armstrong expressed confidence that the Clarity Act, a U.S. federal bill to regulate digital assets, is likely to pass the Senate with broad support from crypto firms and banks. The legislation aims to clarify oversight between the...

Market News
4 hours ago
CNBC
Bullish
news icon
Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.

HIVE Digital appoints Mark Volk to lead global AI revenue growth and surpasses $1M daily revenue in AI and Bitcoin mining.

HIVE Digital Technologies has appointed Mark Volk as Senior Vice President, Revenue at its subsidiary BUZZ HPC to drive global AI infrastructure sales. Volk brings extensive experience from HPE, IBM, and other tech firms to scale BUZZ's GPU-powered A...

Market News
5 hours ago
Newsfile Corp
Bullish
news icon
HIVE Digital appoints Mark Volk to lead global AI revenue growth and surpasses $1M daily revenue in AI and Bitcoin mining.

ZeroRisk raises $10M to expand global cybersecurity services for payment providers.

ZeroRisk, an Irish cybersecurity firm specializing in risk management for payment providers, secured $10 million in a Series A funding round led by MiddleGame Ventures and Elkstone. Founded in 2023, ZeroRisk offers a platform that helps banks and pay...

Market News
5 hours ago
PRNewsWire
Bullish
news icon
ZeroRisk raises $10M to expand global cybersecurity services for payment providers.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $31.89B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $283.28
  • 52W Low
    $182.82
  • Typical Hold Time
    -
  • Enterprise Value
    $31.24B
  • Div Yield
    1.19%
  • Trading Activity
    -
$219.5
52W Low: $182.82
02 Jun 2026
52W High: $283.28
07 Oct 2025

Track ResMed Inc. (RMD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ResMed Inc. has traded between a low of $182.82 and a high of $283.28, highlighting its annual price range. Buy and sell ResMed Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!